Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors

Bioconjugate Chemistry

Volumn 17, Issue 1, 2006, Pages 90-100

  Al Taei, Saly ^a   Penning, Neal A ^a   Simpson, Jeremy C ^b   Futaki, Shiroh ^c,d   Takeuchi, Toshihide ^c   Nakase, Ikuhiko ^c   Jones, Arwyn T ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c KYOTO UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOPHAGES; CELL CULTURE; CELL MEMBRANES; CONTROLLED DRUG DELIVERY; DISEASES; TARGETED DRUG DELIVERY;

CELL-BE; CELL/B.E; CELL/BE; DELIVERY VECTOR; DOWN-STREAM; HEMATOPOIETIC CELL LINE; HIV-TAT; INTRACELLULAR DELIVERY; PROTEIN TRANSDUCTION DOMAINS; SPATIAL INFORMATIONS;

PEPTIDES;

ARGININE; CYTOCHALASIN D; DEOXYRIBONUCLEOPROTEIN; NOCODAZOLE; PEPTIDE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; CELL FATE; DERIVATIZATION; DRUG DELIVERY SYSTEM; DRUG UTILIZATION; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; HEMATOPOIETIC CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERNALIZATION; MACROMOLECULE; NONHUMAN; PROTEIN DOMAIN; PROTEIN TRANSPORT;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 31544479580     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc050274h     Document Type: Article

References (59)

1. Joliot, A., and Prochiantz, A. (2004) Transduction peptides: from technology to physiology. Nat. Cell Biol. 6, 189-96.
2. Snyder, E. L., and Dowdy, S. F. (2004) Cell penetrating peptides in drug delivery. Pharm. Res. 21, 389-93.
3. Deshayes, S., Morris, M. C., Divita, G., and Heitz, F. (2005) Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell. Mol. Life Sci. 62, 1839-49.
4. Fischer, R., Fotin-Mleczek, M., Hufnagel, H., and Brock, R. (2005) Break on through to the Other Side-Biophysics and Cell Biology Shed Light on Cell-Penetrating Peptides. Chembiochem, in press.
5. Beerens, A. M., Al Hadithy, A. F., Rots, M. G., and Haisma, H. J. (2003) Protein transduction domains and their utility in gene therapy. Curr. Gene Ther. 3, 486-94.
6. Wadia, J. S., and Dowdy, S. F. (2003) Modulation of cellular function by TAT mediated transduction of full length proteins. Curr. Protein Pept. Sci. 4, 97-104.
7. Wadia, J. S., and Dowdy, S. F. (2005) Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Adv. Drug Delivery Rev. 57, 579-96.
8. Green, I., Christison, R., Voyce, C. J., Bundell, K. R., and Lindsay, M. A. (2003) Protein transduction domains: are they delivering? Trends Pharmacol. Sci. 24, 213-5.
9. Rudolph, C., Schillinger, U., Ortiz, A., Tabatt, K., Plank, C., Muller, R. H., and Rosenecker, J. (2004) Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo. Pharm. Res. 21, 1662-9.
10. Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., and Lebleu, B. (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278, 585-90.
11. Vives, E., Richard, J. P., Rispal, C., and Lebleu, B. (2003) TAT peptide internalization: seeking the mechanism of entry. Curr. Protein Pept. Sci. 4, 125-32.
12. Lundberg, M., Wikstrom, S., and Johansson, M. (2003) Cell surface adherence and endocytosis of protein transduction domains. Mol. Ther. 8, 143-50.
13. Ferrari, A., Pellegrini, V., Arcangeli, C., Fittipaldi, A., Giacca, M., and Beltram, F. (2003) Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. Mol. Ther. 8, 284-94.
14. Fischer, R., Kohler, K., Fotin-Mleczek, M., and Brock, R. (2004) A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. J. Biol. Chem. 279, 12625-35.
15. Tkachenko, A. G., Xie, H., Liu, Y., Coleman, D., Ryan, J., Glomm, W. R., Shipton, M. K., Franzen, S., and Feldheim, D. L. (2004) Cellular trajectories of Peptide-modified gold particle complexes: comparison of nuclear localization signals and Peptide transduction domains. Bioconjugate Chem. 15, 482-90.
16. Wadia, J. S., Stan, R. V., and Dowdy, S. F. (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10, 310-5.
17. Brooks, H., Lebleu, B., and Vives, E. (2005) Tat peptide-mediated cellular delivery: back to basics. Adv. Drug Delivery Rev. 57, 559-77.
18. Fischer, P. M., Krausz, E., and Lane, D. P. (2001) Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation. Bioconjugate Chem. 12, 825-41.
19. Fretz, M. M., Koning, G. A., Mastrobattista, E., Jiskoot, W., and Storm, G. (2004) OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis. Biochim. Biophys. Acta 1665, 48-56.
20. Vendeville, A., Rayne, F., Bonhoure, A., Bettache, N., Montcourrier, P., and Beaumelle, B. (2004) HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Mol. Biol. Cell 15, 2347-60.
21. Norgaard, J. M., Olesen, L. H., and Hokland, P. (2004) Changing picture of cellular drug resistance in human leukemia. Crit. Rev. Oncol. Hematol. 50, 39-49.
22. Lea, N. C., Buggins, A. G., Orr, S. J., Mufti, G. J., and Thomas, N. S. (2003) High efficiency protein transduction of quiescent and proliferating primary hematopoietic cells. J. Biochem. Biophys. Methods 55, 251-8.
23. Mazel, M., Clair, P., Rousselle, C., Vidal, P., Scherrmann, J. M., Mathieu, D., and Temsamani, J. (2001) Doxorubicin-peptide conjugates overcome multidrug resistance. Anticancer Drugs 12, 107-16.
24. Rink, H. (1987) Solid-phase synthesis of protected peptide fragments using a trialkoxy-diphenyl-methylester resin. Tetrahedron Lett. 28, 3787-3790.
25. Atherton, E., and Sheppard, R. C. (1989) Solid-Phase Peptide Synthesis: A Practical Approah, RL Press, Oxford.
26. Futaki, S., Ishikawa, T., Niwa, M., Kitagawa, K., and Yagami, T. (1997) Embodying a stable alpha-helical protein structure through efficient chemical ligation via thioether formation. Bioorg. Med. Chem. 5, 1883-91.
27. Nakase, I., Niwa, M., Takeuchi, T., Sonomura, K., Kawabata, N., Koike, Y., Takehashi, M., Tanaka, S., Ueda, K., Simpson, J. C., Jones, A. T., Sugiura, Y., and Futaki, S. (2004) Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol. Ther. 10, 1011-22.
28. Simpson, J. C., Griffiths, G., Wessling-Resnick, M., Fransen, J. A., Bennett, H., and Jones, A. T. (2004) A role for the small GTPase Rab21 in the early endocytic pathway. J. Cell Sci. 117, 6297-311.
29. Kauppi, M., Simonsen, A., Bremnes, B., Vieira, A., Callaghan, J., Stenmark, H., and Olkkonen, V. M. (2002) The small GTPase Rab22 interacts with EEA1 and controls endosomal membrane trafficking. J. Cell Sci. 115, 899-911.
30. Maxfield, F. R., and McGraw, T. E. (2004) Endocytic recycling. Nat. Rev. Mol. Cell Biol. 5, 121-32.
31. Mellman, I. (1996) Membranes and sorting. Curr. Opin. Cell Biol. 8, 497-8.
32. Baravalle, G., Schober, D., Huber, M., Bayer, N., Murphy, R. F., and Fuchs, R. (2005) Transferrin recycling and dextran transport to lysosomes is differentially affected by bafilomycin, nocodazole, and low temperature. Cell Tissue Res. 320, 99-113.
33. Bright, N. A., Gratian, M. J., and Luzio, J. P. (2005) Endocytic delivery to lysosomes mediated by concurrent fusion and kissing events in living cells. Curr. Biol. 15, 360-5.
34. Shpetner, H., Joly, M., Hartley, D., and Corvera, S. (1996) Potential sites of PI-3 kinase function in the endocytic pathway revealed by the PI-3 kinase inhibitor, wortmannin. J. Cell Biol. 132, 595-605.
35. Backer, J. M. (2000) Phosphoinositide 3-kinases and the regulation of vesicular trafficking. Mol. Cell Biol. Res. Commun. 3, 193-204.
36. Murray, J. W., and Wolkoff, A. W. (2003) Roles of the cytoskeleton and motor proteins in endocytic sorting. Adv. Drug. Delivery Rev. 55, 1385-403.
37. West, M. A., Bretscher, M. S., and Watts, C. (1989) Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells. J. Cell Biol. 109, 2731-9.
38. Rich, I. N., Worthington-White, D., Garden, O. A., and Musk, P. (2000) Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na(+)/H(+) exchanger. Blood 95, 1427-34.
39. Kaplan, I. M., Wadia, J. S., and Dowdy, S. F. (2005) Cationic TAT peptide transduction domain enters cells by macropinocytosis. J. Controlled Release 102, 247-53.
40. Bright, N. A., Lindsay, M. R., Stewart, A., and Luzio, J. P. (2001) The relationship between lumenal and limiting membranes in swollen late endocytic compartments formed after wortmannin treatment or sucrose accumulation. Traffic 2, 631-42.
41. Fernandez-Borja, M., Wubbolts, R., Calafat, J., Janssen, H., Divecha, N., Dusseljee, S., and Neefjes, J. (1999) Multivesicular body morphogenesis requires phosphatidyl-inositol 3- kinase activity. Curr. Biol. 9, 55-8.
42. Lippincott-Schwartz, J., Yuan, L. C., Bonifacino, J. S., and Klausner, R. D. (1989) Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell 56, 801-13.
43. Doms, R. W., Russ, G., and Yewdell, J. W. (1989) Brefeldin A redistributes resident and itinerant Golgi proteins to the endoplasmic reticulum. J. Cell Biol. 109, 61-72.
44. Lippincott-Schwartz, J., Donaldson, J. G., Schweizer, A., Berger, E. G., Hauri, H. P., Yuan, L. C., and Klausner, R. D. (1990) Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway. Cell 60, 821-36.
45. Reaves, B., and Banting, G. (1992) Perturbation of the morphology of the trans-Golgi network following Brefeldin A treatment: redistribution of a TGN-specific integral membrane protein, TGN38. J. Cell Biol. 116, 85-94.
46. Green, S. A., Zimmer, K. P., Griffiths, G., and Mellman, I. (1987) Kinetics of intracellular transport and sorting of lysosomal membrane and plasma membrane proteins. J. Cell Biol. 105, 1227-40.
47. Griffiths, G., Back, R., and Marsh, M. (1989) A quantitative analysis of the endocytic pathway in baby hamster kidney cells. J. Cell Biol. 109, 2703-20.
48. Collot, M., Louvard, D., and Singer, S. J. (1984) Lysosomes are associated with microtubules and not with intermediate filaments in cultured fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 81, 788-92.
49. Gruenberg, J., Griffiths, G., and Howell, K. E. (1989) Characterization of the early endosome and putative endocytic carrier vesicles in vivo and with an assay of vesicle fusion in vitro. J. Cell Biol. 108, 1301-16.
50. Kuronita, T., Eskelinen, E. L., Fujita, H., Saftig, P., Himeno, M., and Tanaka, Y. (2002) A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology. J. Cell Sci. 115, 4117-31.
51. Saalik, P., Elmquist, A., Hansen, M., Padari, K., Saar, K., Viht, K., Langet, U., and Pooga, M. (2004) Protein cargo delivery properties of cell-penetrating peptides. A comparative study. Bioconjugate Chem. 15, 1246-53.
52. Potocky, T. B., Menon, A. K., and Gellman, S. H. (2003) Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells. J. Biol. Chem. 278, 50188-94.
53. Scherer, P. E., Lewis, R. Y., Volonte, D., Engelman, J. A., Galbiati, F., Couet, J., Kohtz, D. S., van Donselaar, E., Peters, P., and Lisanti, M. P. (1997) Cell-type and tissue-specific expression of caveolin-2. Caveoliris 1 and 2 co-localize and form a stable heterooligomeric complex in vivo. J. Biol. Chem. 272, 29337-46.
54. Richard, J. P., Melikov, K., Brooks, H., Prevot, P., Lebleu, B., and Chernomordik, L. V. (2005) Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J. Biol. Chem. 280, 15300-15306.
55. Weisz, O. A. (2003) Organelle acidification and disease. Traffic 4, 57-64.
56. Drin, G., Cottin, S., Blanc, E., Rees, A. R., and Temsamani, J. (2003) Studies on the internalization mechanism of cationic cell-penetrating peptides. J. Biol. Chem. 278, 31192-201.
57. Green, E. G., Ramm, E., Riley, N. M., Spiro, D. J., Goldenring, J. R., and Wessling-Resnick, M. (1997) Rab11 is associated with transferrin-containing recycling compartments in K562 cells. Biochem. Biophys. Res. Commun. 239, 612-6.
58. Jin, M., and Snider, M. D. (1993) Role of microtubules in transferrin receptor transport from the cell surface to endosomes and the Golgi complex. J. Biol. Chem. 268, 18390-7.
59. Gammon, S. T., Villalobos, V. M., Prior, J. L., Sharma, V., and Piwnica-Worms, D. (2003) Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: chiral and sequence-specific effects on net cell uptake. Bioconjugate Chem. 14, 368-76.